Policies and guidelines

Rethink 2020 summary fact sheet

Rethink 2020 State Plan 2020-2025

Advisory Notice 7/2020: Medical advisory committee chairperson

Selling smoking products: guide for retailers

Advisory Notice 5/2020: Maternity patients - escalation to tertiary level care

Mental Health Act Consultation Amendment Bill and Guide

Tasmanian Procedure for the Approval of Yellow Fever Vaccination Centres and Accreditation of Practitioners

Interagency Drug Policy Committee (IDPC) terms of reference

Interim guidance for the delivery of medication assisted treatment of opioid dependence in response to COVID-19

Advisory Notice 6/2020: Consent requirements for medical treatment

Advisory Notice 4/2020: Introduction of new medical devices or procedures within Tasmanian private health service establishments

Nurse Practitioner Authorisation to Prescribe Scheduled Substances

Nurse Practitioner Authorisation to Prescribe Scheduled Substances

Guide for Licensed Supplier - Radiation apparatus

Laboratory Guidelines for Notifiable Water Contaminants

Tasmanian Drug Strategy 2013-2018 - Report on activities

Guide for the management of Clandestine Drug Laboratories

Consumer Engagement Model of Care: A Framework for Patient Centred Care

Advisory 06: Form 10A and commencement of regulations (for residential aged care facilities)

Advisory Notice 3/2019: Provision of information - issue of infringement notices